Disease
Paragraphs

STANFORD, Calif.- For the past seven years, the United States has been negotiating a verification protocol to the Biological Weapons Convention of 1972, hoping to put teeth into the convention's ban on biological weapons production. The Bush administration recently rejected the latest draft of the protocol, viewing it as irredeemably flawed. This is a good time to ask what a new American strategy should be for security against biological threats. It is difficult to predict the likelihood or scale of biological attack. The right policy will provide benefits whether or not an attack occurs.

The first step is conceptual: we must stop thinking about biological security in the way we think about nuclear security. Few aspects of the United States strategy for nuclear security carry over cleanly to the biological case. Security against nuclear attack has relied upon nonproliferation and deterrence, with comparatively little role, so far, for defense. Security against biological-weapons threats should lean primarily on defense.

Nonproliferation, for example, is far more difficult in the biological case. Biological agents are microscopic organisms that can be grown with equipment readily available all over the world -- although the resulting weapons have proved difficult for terrorists to master. Many of the organisms can be acquired during naturally occurring outbreaks. Controls remain valuable, but they will never play the central role that they do in nuclear security. And as biotechnology explodes in the coming decades, nonproliferation will face ever greater challenges.

Deterrence may likewise be of limited use in preventing attacks with biological weapons. While the use of battlefield biological weapons may be deterred by threats, biological terrorism could remain largely immune. The incubation times of most diseases -- for example, seven to 17 days for smallpox -- may lead terrorists to hope they can cover their tracks through covert releases of biological agents. Deterrence relies on the threat of punishment. An attacker who cannot be identified cannot be threatened.

When the Aum Shinrikyo cultists sprayed an anthrax organism in Tokyo -- they did so unsuccessfully several times before their deadly 1995 nerve-gas attack -- they made no announcements and the attacks went unnoticed. When followers of the Bhagwan Shree Rajneesh infected 750 Oregonians in 1984 with salmonella, it took over a year for the attack to be distinguished from a natural outbreak.

Rather than nonproliferation and deterrence, biological security must emphasize civil defense. Civil defense in the biological realm means improving the public health system. Most important, it requires improving disease surveillance. Unusual disease outbreaks must be recognized quickly, so that a rapid response is possible. Health care workers in clinics, hospitals and private practice must know how to identify such outbreaks and be ready and able to pass their information rapidly to city, state and national authorities.

This kind of preparedness would also help to prevent unintentional outbreaks of disease. Because infected passengers can travel the world in less time than it takes for a disease to incubate, it is crucial, for the national interest as well as for humanitarian reasons, to improve disease surveillance overseas. The United States welcomes 50 million visitors every year and imports $40 billion worth of food. Disease cannot be stopped at the border. The United States must act internationally as well as nationally.

Because biological security would offer protection against both natural and nefarious transmission of disease, a sound policy would directly benefit society even if no attack ever happened. Effective biological security requires that we fit the cure to the disease.

All Publications button
1
Publication Type
Commentary
Publication Date
Journal Publisher
The New York Times
Authors
Christopher F. Chyba
-

Cubberly Auditorium, School of Education, Stanford University

(650) 725-6501
0
Michael and Barbara Berberian Professor (emeritus) at FSI and Engineering
rsd15_078_0380a.jpg
MS, PhD

William Perry is the Michael and Barbara Berberian Professor (emeritus) at Stanford University. He is a senior fellow at the Freeman Spogli Institute and the Hoover Institution, and serves as director of the Preventive Defense Project. He is an expert in U.S. foreign policy, national security and arms control. He was the co-director of CISAC from 1988 to 1993, during which time he was also a part-time professor at Stanford. He was a part-time lecturer in the Department of Mathematics at Santa Clara University from 1971 to 1977.

Perry was the 19th secretary of defense for the United States, serving from February 1994 to January 1997. He previously served as deputy secretary of defense (1993-1994) and as under secretary of defense for research and engineering (1977-1981). Dr. Perry currently serves on the Defense Policy Board (DPB). He is on the board of directors of Covant and several emerging high-tech companies. His previous business experience includes serving as a laboratory director for General Telephone and Electronics (1954-1964); founder and president of ESL Inc. (1964-1977); executive vice-president of Hambrecht & Quist Inc. (1981-1985); and founder and chairman of Technology Strategies & Alliances (1985-1993). He is a member of the National Academy of Engineering and a fellow of the American Academy of Arts and Sciences.

From 1946 to 1947, Perry was an enlisted man in the Army Corps of Engineers, and served in the Army of Occupation in Japan. He joined the Reserve Officer Training Corps in 1948 and was a second lieutenant in the Army Reserves from 1950 to 1955. He was awarded the Presidential Medal of Freedom in 1997 and the Knight Commander of the British Empire in 1998. Perry has received a number of other awards including the Department of Defense Distinguished Service Medal (1980 and 1981), and Outstanding Civilian Service Medals from the Army (1962 and 1997), the Air Force (1997), the Navy (1997), the Defense Intelligence Agency (1977 and 1997), NASA (1981) and the Coast Guard (1997). He received the American Electronic Association's Medal of Achievement (1980), the Eisenhower Award (1996), the Marshall Award (1997), the Forrestal Medal (1994), and the Henry Stimson Medal (1994). The National Academy of Engineering selected him for the Arthur Bueche Medal in 1996. He has received awards from the enlisted personnel of the Army, Navy, and the Air Force. He has received decorations from the governments of Albania, Bahrain, France, Germany, Hungary, Japan, Korea, Poland, Slovenia, and Ukraine. He received a BS and MS from Stanford University and a PhD from Pennsylvania State University, all in mathematics.

Director of the Preventive Defense Project at CISAC
FSI Senior Fellow
CISAC Faculty Member
Not in Residence
Date Label
William Perry Former Secretary of Defense Moderator CISAC
George Fidas Deputy National Inteligence Officer for Global and Multilateral Issues Panelist National Intelligence Council
Margaret Hamburg Former Assistant Secretary of Health Panelist Nuclear Threat Initiative
James Hughes Director Panelist National Center for Infectious Diseases
Panel Discussions

Professor Joshua Lederberg, a research geneticist, is Sackler Foundation Scholar, President-emeritus at The Rockefeller University in New York, and a consulting professor of the Institute for International Studies at Stanford University. Dr. Lederberg was educated at Columbia and Yale University, where he pioneered in the field of bacterial genetics with the discovery of genetic recombination in bacteria. In 1958, at the age of 33, Dr. Lederberg received the Nobel Prize in Physiology of Medicine for this work. Dr. Lederberg has been a professor of genetics at the University of Wisconsin and then at Stanford University School of Medicine, until he came to The Rockefeller University in 1978. A member of the National Academy of Sciences since 1957, and a charter member of its Institute of Medicine, Dr. Lederberg has been active in many government advisory roles, including the Defense Science Board and the Chair of the President's Cancer Panel. He has long had a keen interest in international health, and has served two terms on WHO's Advisory Health Research Council and on the boards of the Center for Strategic and International Studies (Washington) and the Council on Foreign Relations (New York). He co-chaired the IOM's study on Emerging Infections, and recently edited "Biological Weapons: Containing the Threat", published by the MIT Press.

Bechtel Center, Encina Hall

Joshua Lederberg President Emeritus, Rockefeller University and Consulting Professor at CISAC Keynote Speaker Stanford University
Conferences
Paragraphs

The Twenty-fifth Amendment to the Constitution evolved as a response to the need to relieve a sick and disabled president fromthe responsibilities of office, in the best interests of both the sick president and the nation. The congressional hearings that preceded and accompanied its enactment made clear that some members of Congress understood the need for objective medical information to be available to the vice president andCabinet before they couldmake the political determination of disability.Nevertheless, not a single physician was called to testify or advise in the Senate or the House despite the fact that they represent the only societal repository of expertise on physical and mental impairment. Nor was any mechanism defined whereby a dispassionate medical appraisal of the cognitive competence of the president could be obtained if it were in question. Instead, there was an implicit reliance on the physician to the president, whose conflict of interest is so strong that he or she has been used in the past more to conceal than to reveal the true state of the president’s health. The Twenty-fifth Amendment remains a vital mechanism for ensuring the stability of the presidency. But its disability provisions (sections 3 and 4) have not been implemented as the framers intended. Sooner or later, the nation will be confronted with a president who has Alzheimer’s disease, brain trauma, or illness such that his cognitive faculties are not up to the demands of office. A powerful antidote to the White House cover-ups of the past would be a medical advisory committee on the health of the president, created by congressional action. The committee would review the president’s health annually and report to the nation on its significant findings; it also would be convened urgently to assess his health status whenever it was in serious question. It would then advise the vice president and Cabinet of the degree of presidential impairment to provide a scientific medical foundation for the political decision as to the presence or absence of disability. The independence, breadth of expertise, lack of conflict of interest, availability, and credibility of the committee would assure the public of an objective appraisal and would preclude inaction by the executive branch in the face of disability. The arguments against such an advisory committee—that physicians would decide rather than advise; that they might disagree; that they might harass the president or violate confidentiality; and that the committee is unnecessary,would function poorly,
could not assemble quickly, and would infringe on the separation of powers doctrine —have been carefully analyzed and been found wanting. Because the advantages of establishing a medical advisory committee are compelling, it should be the subject of congressional action before, rather than after, the next medical cover-up in the White
House and the accompanying public crisis of confidence.

All Publications button
1
Publication Type
Journal Articles
Publication Date
Journal Publisher
Presidential Studies Quarterly
Authors
Herbert L. Abrams
Paragraphs

Disabling illness has been widely observed among national leaders. This is hardly unexpected because many of them govern at an age when there is a high incidence of debilitating disease. Age became an important issue during the presidential campaign of 1996 because Senator Dole was the oldest candidate ever nominated for a first term. Polls demonstrated a substantial level of concern in the electorate, particularly among older Americans.

The heightened risk of disability or death from heart disease, stroke, and cancer at age 70 and over was one important consideration. It raised doubts as to whether a 73-year-old president would be able to fulfill his implicit contract to serve 208 weeks in office. A second related element was the profound change in cognitive capacities known to be associated with those diseases, even when the symptoms and physical impairment are stable or have improved. Finally, quite separate from the cognitive impairment of illness, age itself carries with it on average a decline in mental acuity, efficient information processing, memory, problem solving, and other requisites of effective decision making. Many older voters reacted to Dole as they did because of their awareness that their own memory, concentration, and energy levels had diminished over the years, sometimes drastically.

In spite of the national concern about job discrimination of any kind, including that based on age, it seems clear that mandatory retirement for chief executive officers at the age of 65 will continue to be an important tenet of our great corporations. Similarly, the most demanding job in the world--the U.S. presidency--need not be imposed on senior citizens. Congress should craft a resolution expressing its conviction that 65 should be the upper age limit for candidates running for a first term as president of the United States.

All Publications button
1
Publication Type
Working Papers
Publication Date
Journal Publisher
CISAC
Authors
Herbert L. Abrams
Subscribe to Disease